Search for a clinical trial
Other search option(s)
20 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
ITALY
LAZIO
ROMA
Effect of riluzole as a symptomatic approach in patients with chronic cerebellar ataxia
A.O. S. Andrea
U.O.C. di Neurologia
AUSTRIA
TIROL
INNSBRUCK
MOXIe: A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia - AT
Medizinische Universität Innsbruck
Universitätsklinik für Neurologie
AUSTRIA
TIROL
INNSBRUCK
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia - AT
Medizinische Universität Innsbruck
Universitätsklinik für Neurologie
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
TALAPRO-1: A phase 2, open-label, response rate study of talazoparib in men with DNA repair defects metastatic castration-resistant prostate cancer who previously received taxane-based chemotherapy and progressed on at least 1 novel hormonal agent (enzalutamide and/or abiraterone acetate/prednisone) - AT
Institution: Information not provided - AT
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
FRAMES: A Double-Blind, Placebo-controlled Study on the Effects of MIN-102 on Biochemical, Imaging, Neurophysiological and Clinical Markers in Patients With Friedreich's Ataxia - BE
Erasme Hospital - ULB
Neurologie
BELGIUM
VLAAMS BRABANT
LEUVEN
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study - BE
UZ Leuven - Campus Gasthuisberg
Laboratory of Pediatric Immunology
FRANCE
ILE-DE-FRANCE
PARIS
AOA1 : Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 (Phase III)
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Institut du Cerveau et de la Moëlle épinière - INSERM U1127
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients with Ataxia Telangiectasia -DE-
Institution: Information not provided - DE
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Institution: Information not provided - DE
GERMANY
Hessen
FRANKFURT AM MAIN
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Schwerpunkt Allergologie, Pneumologie und Mukoviszidose
GERMANY
Nordrhein-Westfalen
AACHEN
SNT-III-001-E (MICONOS Extension):A Phase III open-label, single-group, extension study to obtain long-term safety and tolerability data of Idebenone in the treatment of Friedreich Ataxia patients - DE
Universitätsklinikum Aachen
GeNeMove - Netzwerksekretariat
GERMANY
Nordrhein-Westfalen
AACHEN
FRAMES: A Double-Blind, Placebo-controlled Study on the Effects of MIN-102 on Biochemical, Imaging, Neurophysiological and Clinical Markers in Patients With Friedreich's Ataxia -DE-
Universitätsklinikum Aachen
Klinik für Neurologie
GERMANY
Nordrhein-Westfalen
AACHEN
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (Phase II) -DE-
Universitätsklinikum Aachen
Klinik für Neurologie
SPAIN
Madrid
MADRID
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (Phase II) - ES
Hospital Carlos III
Unidad de ELA
SPAIN
Madrid
MADRID
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study (Phase III) - ES
Hospital Universitario La Paz
Servicio de Neurología
UNITED KINGDOM
Greater London
LONDON
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia-GB
University College London - UCL Darwin Building
University College London
Multinational clinical trial(s)
CANADA
Ontario
WESTON
An Open-label, Single Treatment, Safety and Efficacy, Long-term Study of Deferiprone in Subjects With Friedreich's Ataxia (Phase II) (coordination)
Apotex Inc.
ApoPharma Inc.
CANADA
Ontario
WESTON
A Six-Month Double-Blind, Randomized, Placebo-Controlled Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia (Phase I-II) (coordination)
Apotex Inc.
ApoPharma Inc.
GERMANY
Nordrhein-Westfalen
AACHEN
NICOFA: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
Universitätsklinikum Aachen
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT